207 related articles for article (PubMed ID: 36151850)
21. Neurodevelopmental atypisms in the context of joint hypermobility, hypermobility spectrum disorders, and Ehlers-Danlos syndromes.
Baeza-Velasco C
Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):491-499. PubMed ID: 34741402
[TBL] [Abstract][Full Text] [Related]
22. The Ehlers-Danlos Syndromes against the Backdrop of Inborn Errors of Metabolism.
Van Damme T; Colman M; Syx D; Malfait F
Genes (Basel); 2022 Jan; 13(2):. PubMed ID: 35205310
[TBL] [Abstract][Full Text] [Related]
23. Considerations for lactation with Ehlers-Danlos syndrome: a narrative review.
Francis J; Dickton DD
Int Breastfeed J; 2022 Jan; 17(1):4. PubMed ID: 34983567
[TBL] [Abstract][Full Text] [Related]
24. Nosology and inheritance pattern(s) of joint hypermobility syndrome and Ehlers-Danlos syndrome, hypermobility type: a study of intrafamilial and interfamilial variability in 23 Italian pedigrees.
Castori M; Dordoni C; Valiante M; Sperduti I; Ritelli M; Morlino S; Chiarelli N; Celletti C; Venturini M; Camerota F; Calzavara-Pinton P; Grammatico P; Colombi M
Am J Med Genet A; 2014 Dec; 164A(12):3010-20. PubMed ID: 25338840
[TBL] [Abstract][Full Text] [Related]
25. Dermatologic manifestations and diagnostic assessments of the Ehlers-Danlos syndromes: A clinical review.
Doolan BJ; Lavallee M; Hausser I; Pope FM; Seneviratne SL; Winship IM; Burrows NP
J Am Acad Dermatol; 2023 Sep; 89(3):551-559. PubMed ID: 36764582
[TBL] [Abstract][Full Text] [Related]
26. Joint hypermobility syndrome (a.k.a. Ehlers-Danlos Syndrome, Hypermobility Type): an updated critique.
Castori M
G Ital Dermatol Venereol; 2013 Feb; 148(1):13-36. PubMed ID: 23407074
[TBL] [Abstract][Full Text] [Related]
27. Ehlers-Danlos syndromes: importance of defining the type.
van Dijk FS; Ghali N; Chandratheva A
Pract Neurol; 2024 Mar; 24(2):90-97. PubMed ID: 38160052
[TBL] [Abstract][Full Text] [Related]
28. Gender dysphoria in adolescents with Ehlers-Danlos syndrome.
Jones JT; Black WR; Moser CN; Rush ET; Malloy Walton L
SAGE Open Med; 2022; 10():20503121221146074. PubMed ID: 36600979
[TBL] [Abstract][Full Text] [Related]
29. The association between Ehlers-Danlos syndrome-hypermobility type and gastrointestinal symptoms in university students: a cross-sectional study.
Fikree A; Aktar R; Morris JK; Grahame R; Knowles CH; Aziz Q
Neurogastroenterol Motil; 2017 Mar; 29(3):. PubMed ID: 27683076
[TBL] [Abstract][Full Text] [Related]
30. A review of Ehlers-Danlos syndrome.
Miller E; Grosel JM
JAAPA; 2020 Apr; 33(4):23-28. PubMed ID: 32175940
[TBL] [Abstract][Full Text] [Related]
31. Contemporary approach to joint hypermobility and related disorders.
Castori M; Hakim A
Curr Opin Pediatr; 2017 Dec; 29(6):640-649. PubMed ID: 28906340
[TBL] [Abstract][Full Text] [Related]
32. Diagnosis and treatment of the Ehlers-Danlos syndromes in China: synopsis of the first guidelines.
Xu K; Li G; Wu Z; Zhang TJ; Wu N;
Orphanet J Rare Dis; 2024 May; 19(1):194. PubMed ID: 38741208
[TBL] [Abstract][Full Text] [Related]
33. Relationship between fatigue and gait abnormality in joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type.
Celletti C; Galli M; Cimolin V; Castori M; Albertini G; Camerota F
Res Dev Disabil; 2012; 33(6):1914-8. PubMed ID: 22819599
[TBL] [Abstract][Full Text] [Related]
34. Hypermobile Ehlers-Danlos Syndrome and Hypermobility Spectrum Disorders.
Yew KS; Kamps-Schmitt KA; Borge R
Am Fam Physician; 2021 Apr; 103(8):481-492. PubMed ID: 33856167
[TBL] [Abstract][Full Text] [Related]
35. Knowledge, assessment, and management of adults with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type among Flemish physiotherapists.
Rombaut L; Deane J; Simmonds J; De Wandele I; De Paepe A; Malfait F; Calders P
Am J Med Genet C Semin Med Genet; 2015 Mar; 169C(1):76-83. PubMed ID: 25821093
[TBL] [Abstract][Full Text] [Related]
36. Subjective health complaints and illness perception amongst adults with Joint Hypermobility Syndrome/Ehlers-Danlos Syndrome-HypermobilityType - a cross-sectional study.
Hope L; Juul-Kristensen B; Løvaas H; Løvvik C; Maeland S
Disabil Rehabil; 2019 Feb; 41(3):333-340. PubMed ID: 29041819
[TBL] [Abstract][Full Text] [Related]
37. Initial description and evaluation of EDS ECHO: An international effort to improve care for people with the Ehlers-Danlos syndromes and hypermobility spectrum disorders.
Schubart JR; Bascom R; Francomano CA; Bloom L; Hakim AJ
Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):609-615. PubMed ID: 34821464
[TBL] [Abstract][Full Text] [Related]
38. Oral manifestations of Ehlers-Danlos syndromes.
Lepperdinger U; Zschocke J; Kapferer-Seebacher I
Am J Med Genet C Semin Med Genet; 2021 Dec; 187(4):520-526. PubMed ID: 34741498
[TBL] [Abstract][Full Text] [Related]
39. Ehlers-Danlos syndrome, classical type: case management.
Whitelaw SE
Dermatol Nurs; 2004 Oct; 16(5):433-6, 449. PubMed ID: 15624708
[TBL] [Abstract][Full Text] [Related]
40. Ehlers-Danlos Syndromes, Joint Hypermobility and Hypermobility Spectrum Disorders.
Micale L; Fusco C; Castori M
Adv Exp Med Biol; 2021; 1348():207-233. PubMed ID: 34807421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
